Ablative CO2 laser effective for rhinophyma

Good cosmetic outcomes are possible using fractional ablative carbon dioxide (CO2) laser therapy for mild-to-moderate cases of rhinophyma (a condition characterized by prominent pores and a fibrous thickening of the nose, sometimes associated with the common skin condition rosacea), according to researchers at the University of California-Irvine.

Related: Studies report laser treatment reduces bruising, facilitates healing following cosmetic surgery

Related: Fractional ablative lasers minimize burn severity

Kathryn L. Serowka, MD, and colleagues reported treatment of mild-to-moderate rhinophyma in five patients using aggressive parameters with fractional ablative CO2 laser therapy (the laser used for the treatment was the Fraxel re:Pair from Solta Medical [Hayward, CA]). They found that all of the patients, who had relatively mild-to-moderate signs of rhinophyma, tolerated the laser treatment well (settings of up to 70 mJ, 70% density, and 16–18 passes). Reepithelialization and self-limited edema and erythema occurred at four to seven days. No adverse events were reported. Patients and physicians observed improved appearance without the typical scarring caused by most other treatments.

"We were able to demonstrate good improvement in texture, color, and size of mild-to-moderate rhinophyma treated with ablative fractionated carbon dioxide laser," the authors say.

Full details have been published online in the journal Lasers in Surgery and Medicine; for more information, please visit http://onlinelibrary.wiley.com/doi/10.1002/lsm.22184/full.


Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Nanoparticles, NIR laser light combine to destroy cancer cells

A newly developed method that kills cancer cells using nanoparticles and near-infrared laser light.

Novel post-op patch delivers drug, gene, and light therapy to tumor sites

An adhesive patch can stick to a tumor site, either before or after surgery, to deliver a combination of drug, gene, and light therapy.

Low-level laser therapy is a potential noninvasive treatment for thrombocytopenia

Low-level laser therapy may offer a noninvasive, drug-free treatment for a potentially life-threatening bleeding disorder.

NIR light-activated nanoparticles can precisely target and treat tumors

Novel nanoparticles that use heat and near-infrared light can potentially target and ablate tumors with greater precision.


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS